You are here

pediatric

Pfizer completes COVID-19 vaccine application for kids under 5

Pfizer completes COVID-19 vaccine application for kids under 5

Beckers Hospital Review

Flag link:

Masimo's (MASI) PVi Favored by New Study for Pediatric Patients

Masimo's (MASI) PVi Favored by New Study for Pediatric Patients

Yahoo/Zacks.com

Flag link:

FDA advisory panel to meet June 15 to discuss Pfizer, BioNTech and Moderna vaccines for children aged 6 months to 4 years

FDA advisory panel to meet June 15 to discuss Pfizer, BioNTech and Moderna vaccines for children aged 6 months to 4 years

Marketwatch

Moderna Therapeutics

Flag link:

Pfizer/BioNTech to seek Covid vaccine authorization for children under age 5

Pfizer/BioNTech to seek Covid vaccine authorization for children under age 5

Stat

Flag link:

CDC recommends Covid boosters for kids ages 5 to 11 after advisory committee vote

CDC recommends Covid boosters for kids ages 5 to 11 after advisory committee vote

Stat

Flag link:

FDA clears Covid booster shot for healthy kids ages 5 to 11

FDA clears Covid booster shot for healthy kids ages 5 to 11

Stat

Flag link:

Moderna Vaccine Provokes Strong Immune Response in Children 6 to 11

Moderna Vaccine Provokes Strong Immune Response in Children 6 to 11

NY Times, NY

Moderna Therapeutics

Flag link:

FDA's Peter Marks to Congress: Youngest kids vaccine won't need to hit 50% efficacy mark

FDA's Peter Marks to Congress: Youngest kids vaccine won't need to hit 50% efficacy mark

Endpoints

Flag link:

Moderna seeks FDA clearance for COVID-19 vaccine in young children

Moderna seeks FDA clearance for COVID-19 vaccine in young children

BioPharma Dive

Moderna Therapeutics

Flag link:

Pfizer asks FDA to authorize booster shots for kids ages 5 through 11

Pfizer asks FDA to authorize booster shots for kids ages 5 through 11

NPR

Flag link:

Valneva and Pfizer report positive Phase 2 data for Lyme disease vaccine in children

Valneva and Pfizer report positive Phase 2 data for Lyme disease vaccine in children

Biopharma Reporter

clinical trials

Flag link:

FDA approves first COVID treatment for children under 12

FDA approves first COVID treatment for children under 12

Axios

Gilead Sciences

Flag link:

Moderna to file for EUA of COVID-19 shot for very young kids by April end

Moderna to file for EUA of COVID-19 shot for very young kids by April end

Yahoo/Reuters

Moderna Therapeutics

Emergency Use Authorization

Flag link:

Pfizer to seek Covid booster for healthy 5- to 11-year-olds

Pfizer to seek Covid booster for healthy 5- to 11-year-olds

Stat

Flag link:

Gilead unveils pediatric drug development center in Ireland with 33 new jobs

Gilead unveils pediatric drug development center in Ireland with 33 new jobs

Fierce Biotech

Gilead Sciences

drug development

Flag link:

Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use

Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use

Fierce Pharma

pneumococcal disease

Flag link:

Moderna to ask FDA to authorize Covid-19 vaccine in children 6 months to 6 years

Moderna to ask FDA to authorize Covid-19 vaccine in children 6 months to 6 years

Stat

Moderna Therapeutics

Flag link:

Pfizer to begin late-stage testing of Covid-19 antiviral for kids

Pfizer to begin late-stage testing of Covid-19 antiviral for kids

Politico

clinical trials

Flag link:

CDC data suggest Pfizer vaccine protection holds up in kids 5-11, raising questions on earlier study

CDC data suggest Pfizer vaccine protection holds up in kids 5-11, raising questions on earlier study

Stat

Flag link:

Pfizer Shot Is Far Less Effective in 5- to 11-Year-Olds Than in Older Kids, New Data Show

Pfizer Shot Is Far Less Effective in 5- to 11-Year-Olds Than in Older Kids, New Data Show

NY Times, NY

Flag link:

Pages